The Medical Journal of Mazandaran (MJM) is an international quarterly peer review journal which is aimed to promote communication among researchers worldwide and welcomes contributions from authors in all areas of medical sciences. The journal publishes original contributions that have not previously been submitted for publication elsewhere. Full papers and short communications will be considered for publication and reviews, only by invitation. Papers are reviewed and only those that report results of novel, timely and significant research and meet high standards of scientific merit and relevance to the Journal’s scope are accepted for publication. The final decision to accept contributions rests with the Editorial Committee of the MJM. 

 

Manuscripts are received with the understanding that they are submitted solely to the MJM. Upon submission, they become the property of the Publisher and that the data in the manuscript have been reviewed by all authors, who agree with the analysis of the data and the conclusions reached in the manuscript. The Publisher reserves copyright and renewal on all published material and such material may not be reproduced without the written permission of the Publisher. Statements in articles are the responsibility of the authors.

 

Send Four copies of the complete manuscript (one original and 3 copies) together with Four sets of original figures and photographs to: MJM Editorial office, Moallem Square, Sari, Iran, P.O. Box: 48175-866. Submission by e-mail is preferred to mjm.editor@ams.ac.ir

 

 

The following types of articles will be considered for publication:

(1) Research Articles: Reports of original studies related to all issues of medical sciences that are well documented, novel, and significant. Research articles should not exceed 5,000 words, have a total of 6 or fewer tables and figures, an abstract of 250 words or less.

(2) Short communication: Short, definitive reports of highly significant and timely findings. Advances should be 2,000 words long, with an abstract of no more than 150 words, a one-paragraph Introduction, an abbreviated Materials and Methods section, Results and Discussion sections (which may be combined) and no more than a total of 4 tables or figures.

 (3) Reviews: Reviews are only accepted from experts in the field. They should not exceed 6,000 words of text with 5 or fewer tables and figures, an abstract of 250 words, and 100 or fewer references.

 (5) Letters to the Editor: In the spirit of open scientific dialogue, the Editor-in-Chief invites the submission of correspondence that presents considered opinions in response to articles published in the journal. Letters to the Editor will be reviewed and, if found to meet the requisite publication criteria. The Letter may be sent to the author(s) of the originally published article and possibly to other interested parties for a response to be published in the same issue of the journal as the Letter. Letters should have a brief title that references the topic of the originating article, and Letters should not exceed 400 words, with 5 or fewer references and no tables or figures.

 

Language: Manuscripts should be written in clear, grammatical English. The past tense should be used throughout in describing the results and the present tense in referring to previously established and generally accepted results. Authors who are unsure of correct English usage should have their manuscript checked by somebody who is proficient in the language; manuscripts that are deficient in this respect may be returned to the author for revision before scientific review. 

Typing: Manuscripts must be typewritten in a font size of 12 points, double-spaced (including References, Tables and Figure legends) with wide margins (2.5 cm from all sides) on one side of A₄ paper. The beginning of each new paragraph must be clearly indicated by indentation. Each of the following sections should start on a separate page: Abstract, text, references, tables and figure legends. All pages should be numbered consecutively at the bottom starting with the title page.

Title: Write a brief and informative title that identifies the nature of the subject matter. Avoid chemical formulas or abbreviations.

Title page: The title page should include: (a) the full title of the article (b) the authors' full names (first name, middle initial, surname) with degrees and status in the institute; (c) affiliations, institution, city, and state or country where the work was done); (d) acknowledgments of grant support of the study; (e) the name and full address of corresponding author indicated by a star (as well as telephone and facsimile numbers, e-mail address, and if available URL address); and (f) running title (not more than 30 spaces).

Abbreviations: Only common abbreviations, may be used without definition. Terms appearing frequently (three or more times) within a paper may be abbreviated, but should be spelled out at first citation, with the abbreviation following in parentheses.

Abstract: This should not be more than 250 words and should state purpose of the study, basic procedures, most important findings, and principal conclusions. Write the abstract in third person. References should not be cited and abbreviations should be avoided.

Keywords: A list of three to five keywords should be included at the foot of the abstract.

 

 

Introduction: This should contain a description of the problem under investigation and relevant background information and published studies should be described concisely, and be cited appropriately.

Materials and Methods: The methods, apparatus and procedures should be identified in sufficient details. Avoid redescribing methods frequently cited before; only relevant modifications should be included in the text. For experiments on humans, indicate whether the procedures followed were in accord with the standards of the ethics Committee of the institution in which the experiments were done. For drugs the generic name should be used. Trade names may appear in parentheses and should be capitalized.

Results: This section should include the findings of the study. Data should not be repeated in both a Table and a Figure. 

Discussion.  It should relate the results to previous works and interpret them not a simple recapitulate of the Results. 

Acknowledgments: This optional part should include a statement thanking those who assisted substantially with work relevant to the study. Grant support should be included in this section.

References: Authors are responsible for the accuracy of the references. References should be numbered sequentially in the order of their citation in the text and inserted between square brackets, e.g. [1], [6-10]. The list of references should follow the order of their citation with complete listing of authors (if 7 or more authors, list the first 6 authors followed by et al.). Only published, "in press" papers and books may be cited in the reference list. Periodical titles should be abbreviated according to Index Medicus.

 

Journals:

Russell FD, Coppell AL, Davenport AP. In vitro enzymatic processing of radiolabelled big ET-1 in human kidney as a food ingredient. Biochem Pharmacol 1998 Mar 1;55(5):697-701.

 

Books:

Fauci AS, Braunwald E, Isselbacher KJ, Wilson JD, Martin JB, Kasper DL, et al, editors. Harrison's principles of internal medicine. 14th ed. New York: McGraw Hill, Health Professions Division; 1998.

 

Book chapter:

Porter RJ, Meldrum BS. Antiepileptic drugs. In: Katzung BG, editor. Basic and clinical pharmacology. 6th ed. Norwalk, CN: Appleton and Lange; 1995. pp. 361-80.

 

Conference proceedings:

Kimura J, Shibasaki H, editors. Recent advances in clinical neurophysiology. Proceedings of the 10th International Congress of EMG and Clinical Neurophysiology; 1995 Oct 15-19; Kyoto, Japan. Amsterdam: Elsevier; 1996.

 

Online journals:

Morse SS. Factors in the emergence of infectious disease. Emerg Infect Dis [serial online] 1995 Jan-Mar;1(1):[24 screens]. Available from: URL:http://www/cdc/gov/ncidoc/EID/eid.htm. Accessed December 25, 1999.

 

WWW site:

Health on the net foundation. Health on the net foundation code of conduct (HONcode) for medical and health web sites. Available at: http://www.hon.ch/Conduct.html. Accessed June 30, 1998.

 

Tables and Figures: Tables should be so constructed that they, together with their captions and legends, will be intelligible with minimal reference to the text. They should be numbered (1, 2, 3, etc.) as they appear in the text. All hardcopy illustrations should bear the author's name, the orientation (top, bottom, etc.) and be numbered accordingly. Hardcopy colour figures should be submitted as separate prints and not be mounted on cardboard. Photographs must be originals of high quality. Laser quality figures may be submitted.

Reprints: 10 reprints will be provided only to the corresponding author free of charge. Additional copies can be ordered at prices shown on the reprint order form.

Revision: Papers may be returned to authors for modification of the scientific content and/or for shortening and language corrections. A hard copy as well as an electronic copy on an IBM compatible floppy disk of the revised versions must be submitted to the Editor and must be accompanied by a letter listing the changes that have been made. Suggestions by the Editors about resubmission do not imply that a revised version will necessarily be accepted. If a paper that is returned to the authors for modification is not resubmitted within two months it will be regarded as having been withdrawn and any revised version received subsequently will be treated as a new paper. 

Proofs: Proofs will be sent to the corresponding author to be checked for only typographical errors and other essential small changes. Major alterations to the text can not be accepted at this stage. No changes in the name of the authors is permissible at this stage. Proofs must be returned to the Editor within 5 days of receipt.

 

 Copyright: Upon acceptance of a manuscript for publication, authors will beasked totransfer copyright of the article to the MJM.

 

For further information places contact the Editorial office at :

Journal Office, Building No. 2, Mazandaran University of Medical Sciences, Moallem Square,Sari, IRAN.

Tel : (0151) 3261245-8   Postal code: 48175-866

E. Mail: mjm.editor@ams.ac.ir